European Research Hub (ERH)
Developing clinical vascular disease research, together.
Pushing Research Forward
The European Research Hub (ERH) was established in 2022 to increase participation in high quality clinical research in vascular disease throughout Europe and internationally.
Today, ERH serves as the ESVS platform for collaborative research, bringing together clinicians, researchers, partners, and other ESVS committees to facilitate research initiatives, encourage collaboration, and promote the sharing of knowledge and expertise in vascular disease
Its activities include supporting collaborative studies, registries, and innovation projects, while encouraging best practice in research governance, collaboration, and evidence generation. Through its activities, ERH aims to strengthen research capacity across Europe and contribute to advances in vascular care.

How to Join?
Collaboration Request
If you are interested in collaborating with the ERH on a specific project, please download and complete the collaboration form.
Once filled, please send it via email to research@esvs.org.
Participate in the Research Registry
The ERH is involved in several projects, liaising with industry partners and other interested parties. If your centre wants to get involved, please fill in the form.
Your data will be saved in the ERH-Registry of Research Centres, managed by the ESVS. It will only be accessible for members of the ERH, members of the ESVS Executive Committee, and the administrative office of the ESVS.
ERH Initiatives and Collaborations
The European Venous Registry
Integration of Wearable Technology into Vascular Surgery: Insights from an International Online Cross-Sectional Survey
Imaging analysis using Artificial Intelligence to predict outcomes after endovascular aortic aneurysm repair: protocol for a retrospective cohort study
Collaborative Vascular Research in Europe to Improve Care for Patients With Vascular Diseases: What Is Out There, and How to Participate?
Open Survey on Barriers to International Research in Vascular Surgery and Potential Role of the European Society for Vascular Surgery
Patient-Reported Quality of Life After Open Surgery for Complex Abdominal Aortic Aneurysms: A Prospective Multicentre Study
The European Research Hub is supporting a prospective multicentre observational study measuring health-related quality of life (SF-36) across five time points, from before surgery to twelve months, after open repair of complex abdominal aortic aneurysms — the first such data for open complex AAA repair.
Coordinated by Ospedale Regionale di Lugano (EOC, Switzerland) with Luzerner Kantonsspital; further centres are currently being recruited.
Read more about
the European Research Hub
This initiative supports the advancement of vascular surgery training, vascular surgery courses, and vascular surgery procedures.
European Research Hub: European Society for Vascular Surgery Research Initiative Has Materialised
The Key Role of the European Society for Vascular Surgery in Improving the Surveillance of High Risk Medical Devices
Surveys
We’re gathering insights to better understand the challenges and opportunities in clinical research.
European Survey of Post-Revascularization Surveillance Following Lower Limb Endovascular Intervention
Surveillance after lower limb endovascular intervention varies widely across Europe, and there is little evidence or guideline consensus on who should be followed up, how, and for how long. EU-SURVEILL is a short survey that aims to characterise current practice, identify areas of variation and consensus, and inform future research and guideline development.
Who should complete it: vascular surgeons, interventional radiologists, angiologists, vascular scientists/sonographers, specialist nurses and advanced practitioners involved in the care of patients after lower limb endovascular intervention. One response per clinician is welcome; multiple respondents from the same unit are encouraged!
What it covers: surveillance pathways by clinical indication, including chronic limb-threatening ischaemia and diabetes, modalities and timing, who delivers surveillance, triggers for reintervention, and brief clinical scenarios.
